4//SEC Filing
Astex Pharmaceuticals, Inc 4
Accession 0001179110-13-015577
CIK 0000919722operating
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 7:35 PM ET
Size
14.4 KB
Accession
0001179110-13-015577
Insider Transaction Report
Form 4
LACK WALTER J
Director
Transactions
- Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−22,500→ 0 totalExercise: $7.79Exp: 2014-05-06→ Common Stock (22,500 underlying) - Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−45,000→ 0 totalExercise: $2.10Exp: 2022-06-22→ Common Stock (45,000 underlying) - Disposition from Tender
Common Stock
2013-10-11−457,500→ 0 total - Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−30,000→ 0 totalExercise: $5.89Exp: 2017-06-14→ Common Stock (30,000 underlying)
Footnotes (9)
- [F1]Pursuant to the Agreement and Plan of Merger, dated September 5, 2013, between the Issuer, Otsuka Pharmaceutical Co. Ltd., and Autumn Aquisition Corporation (the "Merger Agreement"), each share of Common Stock was exchanged for $8.50 in cash.
- [F2]The option provided for vesting as to 1/4th of the shares on May 6, 2004 and on each three month anniversary thereafter.
- [F3]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $15,975.00, which represents the difference between $8.50 and the exercise price of the option per share.
- [F4]The option provided for vesting as to 1/4th of the shares on June 14, 2007 and on each three month anniversary thereafter.
- [F5]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $78,300.00, which represents the difference between $8.50 and the exercise price of the option per share.
- [F6]The option provided for vesting as to 1/4th of the shares on June 22, 2012 and on each three month anniversary thereafter.
- [F7]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $288,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
- [F8]The option originally provided for vesting as to 1/4th of the shares on June 13, 2013 and on each three month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
- [F9]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $175,500.00, which represents the difference between $8.50 and the exercise price of the option per share.
Documents
Issuer
Astex Pharmaceuticals, Inc
CIK 0000919722
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000919722
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 7:35 PM ET
- Size
- 14.4 KB